National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 507449

History of Changes from the VAERS Wayback Machine

First Appeared on 3/14/2014

VAERS ID: 507449
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:2013-02-09
Submitted:2013-10-14
Entered:2013-10-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / SYR

Administered by: Other      Purchased by: Other
Symptoms: Type 1 diabetes mellitus

Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Insulin
Current Illness: Immunisation
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES1310GBR005165

Write-up:This case was received from the health authority on 04-Oct-2013. GB-MHRA-ADR 22256326. This case is not medically confirmed as it was reported by a consumer. A 12-year-old female patient (weight: 31 kg), with no reported medical history, received on an unreported date an injection of GARDASIL, (batch n. not reported), route, dose in series and site of administration not reported) and on 09-Feb-2013 she experienced type 1 diabetes mellitus. It was unknown if the reaction was treated. However, it was reported that concomitant medication included insulin. At the time of reporting the patient had not recovered. The MHRA considered this case to be serious due to disability, hospitalisation and as a life threatening condition.


Changed on 6/14/2014

VAERS ID: 507449 Before After
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:2013-02-09
Submitted:2013-10-14
Entered:2013-10-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / SYR

Administered by: Other      Purchased by: Other
Symptoms: Type 1 diabetes mellitus

Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Insulin
Current Illness: Immunisation
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES1310GBR005165

Write-up:This case was received from the health authority on 04-Oct-2013. GB-MHRA-ADR 22256326. This case is not medically confirmed as it was reported by a consumer. A 12-year-old female patient (weight: 31 kg), with no reported medical history, received on an unreported date an injection of GARDASIL, (batch n. not reported), route, dose in series and site of administration not reported) and on 09-Feb-2013 she experienced type 1 diabetes mellitus. It was unknown if the reaction was treated. However, it was reported that concomitant medication included insulin. At the time of reporting the patient had not recovered. The MHRA considered this case to be serious due to disability, hospitalisation and as a life threatening condition.


Changed on 3/14/2015

VAERS ID: 507449 Before After
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:2013-02-09
Submitted:2013-10-14
Entered:2013-10-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / - UN / SYR

Administered by: Other      Purchased by: Other
Symptoms: Type 1 diabetes mellitus

Life Threatening? Yes
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: Insulin
Current Illness: Immunisation
Preexisting Conditions:
Diagnostic Lab Data:
CDC 'Split Type': WAES1310GBR005165

Write-up:This case was received from the health authority on 04-Oct-2013. GB-MHRA-ADR 22256326. This case is not medically confirmed as it was reported by a consumer. A 12-year-old female patient (weight: 31 kg), with no reported medical history, received on an unreported date an injection of GARDASIL, (batch n. not reported), route, dose in series and site of administration not reported) and on 09-Feb-2013 she experienced type 1 diabetes mellitus. It was unknown if the reaction was treated. However, it was reported that concomitant medication included insulin. At the time of reporting the patient had not recovered. The MHRA considered this case to be serious due to disability, hospitalisation and as a life threatening condition.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=507449&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166